|
2Y4I
KSR2-MEK1 heterodimer
Deposited 2011-01-06
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–393(393 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.25;293 K;12% (W/V) PEG 3350, 0.2 M NA CITRATE, 10 MM PR ACETATE, BIS-TRIS PROPANE PH 6.25.
|
Resolution 3.46 Å
R-free 0.293
|
|
7JUQ
Crystal Structure of KSR2:MEK1 in complex with ADP
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.22 Å
R-free 0.288
|
|
7JUR
Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Trametinib
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
QOM Trametinib × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;12% PEG-3350, 100 mM MES pH
6.25, 200 mM Magnesium Acetate
|
Resolution 2.82 Å
R-free 0.277
|
|
7JUS
Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
VKD Cobimetinib × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 2.99 Å
R-free 0.265
|
|
7JUT
Crystal Structure of KSR2:MEK1 in complex with ANP-PNP, and allosteric MEK inhibitor Selumetinib
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
3EW 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.09 Å
R-free 0.300
|
|
7JUU
Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
4BM N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.19 Å
R-free 0.258
|
|
7JUV
Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
VKG N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)-N'-methylsulfuric diamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.36 Å
R-free 0.255
|
|
7JUW
Crystal Structure of KSR1:MEK1 in complex with AMP-PNP
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES pH 6.5, Magnesium Acetate
|
Resolution 2.88 Å
R-free 0.286
|
|
7JUX
Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Trametinib
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 1
QOM Trametinib × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.34 Å
R-free 0.283
|
|
7JUY
Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
EUI [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-[3-OXIDANYL-3-[(2S)-PIPERIDIN-2-YL]AZETIDIN-1-YL]METHANONE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.10 Å
R-free 0.257
|
|
7JUZ
Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
3EW 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.21 Å
R-free 0.272
|
|
7JV0
Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 1
4BM N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.63 Å
R-free 0.260
|
|
7JV1
Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1
Deposited 2020-08-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
35–393(359 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 1
VKG N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)-N'-methylsulfuric diamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
|
Resolution 3.62 Å
R-free 0.303
|